Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Macrophages, not stem cells, correct liver disease by fusion

07.07.2004


OHSU study flies in face of belief that plasticity causes stem cells to transform



An Oregon Health & Science University study is defying a long-accepted assertion among many scientists that stem cells repair diseased tissue by transforming into other cell types in a process called plasticity.

The first study from OHSU’s new Oregon Stem Cell Center, published in the current issue of the journal Nature Medicine, found that mature macrophages derived from bone marrow stem cells, and not bone marrow stem cells themselves, are what fuse with diseased liver cells, ultimately curing a genetic liver disease.


"The most important discovery is you don’t need to transplant stem cells at all," said study co-author Markus Grompe, M.D., professor of molecular and medical genetics, and pediatrics, OHSU School of Medicine, and director of the Oregon Stem Cell Center. "If you transplant only macrophages, you’ll get liver cells that correct liver disease in mice."

Holger Willenbring, M.D., postdoctoral fellow of molecular and medical genetics, and the study’s lead author, called fusion between macrophages and hepatocytes, the cells in the liver that provide the typical functions of this organ, "a rare physiological, but potentially therapeutically exploitable, phenomenon."

"Macrophages are known to fuse with themselves," Holger said. "Therefore, it is not absolutely surprising that they can fuse with other cells as well, especially, since macrophages physiologically reside in the liver and comprise a substantial fraction of the liver cells.

Usually, they participate in resolving inflammation, taking care of debris and producing factors that help the liver to function. In addition, they provide a link between the bone marrow compartment and highly specified organ cells, and this is new and exciting because of therapeutic implications."

The findings are the latest in a series of discoveries by Grompe’s laboratory since 2000, when it first showed blood-forming stem cells derived from bone marrow, called hematopoietic stem cells, can cure liver disease in mice. It later found that the liver cells were corrected by cell fusion rather than differentiation of the transplanted stem cells.

"Various labs have reported that bone marrow or blood stem cells are like super cells. They can turn into anything – liver, lung, brain, muscle," Grompe said. "Our thought was that blood stem cells are really there to repair all tissues, and we showed that you can cure liver disease with blood stem cell transplantation.

"Then we found out that the bone marrow cells were not turning into liver cells directly, but that they were fusing with preexisting liver cells instead. In cell fusion, two distinct cells meld to form a single, new cell. The liver cells were turning the blood cells into their own kind."

In the latest study, macrophages derived from bone marrow stem cells were transplanted into the spleens of mice with the genetic liver disease fumarylacetoacetate hydrolase deficiency, also called hereditary tyrosinemia in humans. Each mouse was injected with 1 million macrophages. The spleen, upstream from the liver, slowly releases the macrophages into the liver, which would otherwise wash cells away in its blood-rich environs. The result was "robust production" of functional hepatocytes..

"This means you can get away with using only macrophages in transplantation," Grompe said. "For bone marrow transplantation, to get a stem cell transplant to work, you need to treat the host with lethal doses of preparative irradiation, which has severe side effects. Here we show this harsh treatment is not necessary for macrophages to turn into useful liver cells."

Willenbring said transplantation of macrophages or their immediate, short-lived progenitors is much more targeted toward treatment of damaged liver tissue than using whole stem cells from which they’re derived.

The discovery "strongly argues against stem cell plasticity because you’re not using stem cells at all," Grompe said. To be sure, his laboratory used macrophages exclusively in the transplantation and "it worked." Macrophages also can more easily be grown in tissue culture than stem cells, and future studies will even look at whether they can be genetically modified before transplantation.

"That’s the future. That’s what we’re trying to do," he said.

As for stem cell plasticity, Grompe said he and his colleagues "just don’t see it," at least in liver cell repopulation.

"That could mean two things: We’re blind, or it doesn’t happen," he said. "I think the burden of proof is now on the people doing that work, to show that what they’re seeing is not fusion."

The study was funded by the National Institutes of Health.

Jonathan Modie | EurekAlert!
Further information:
http://www.ohsu.edu

More articles from Studies and Analyses:

nachricht WAKE-UP provides new treatment option for stroke patients | International study led by UKE
17.05.2018 | Universitätsklinikum Hamburg-Eppendorf

nachricht First form of therapy for childhood dementia CLN2 developed
25.04.2018 | Universitätsklinikum Hamburg-Eppendorf

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>